Write a structured well presented poin to point 15 mark answer on hemodialysis for my final year mbbs University proff examination of medicine in pdu medical college, rajkot, gujarat, india
Reading Document
Medical Text Search
hemodialysis principles mechanism indications procedure
Medical Text Search
hemodialysis complications adequacy vascular access
GradeResponse
GradeResponse
Medical Text Search
hemodialysis indications chronic kidney disease end stage renal failure ESRD
Medical Text Search
hemodialysis adequacy Kt/V urea reduction ratio dialysate composition
GradeResponse
GradeResponse
Here is your structured, comprehensive 15-mark answer on Hemodialysis, formatted for PDU Medical College final year MBBS University examination:
HEMODIALYSIS
Definition
Hemodialysis (HD) is an extracorporeal renal replacement therapy (RRT) in which blood is circulated outside the body through a dialyzer (artificial kidney) containing a semipermeable membrane, allowing removal of metabolic waste products, excess fluid, and correction of electrolyte and acid-base abnormalities. (Harrison's, p. 8521)
Principle of Hemodialysis
Three physical processes operate simultaneously:
1. Diffusion (primary mechanism)
- Solutes move down a concentration gradient from blood to dialysate across the semipermeable membrane
- Rate depends on: concentration gradient, membrane surface area, mass transfer coefficient, and molecular size
- Small molecules (urea, 60 Da) are cleared efficiently; larger molecules (creatinine, 113 Da) are cleared less efficiently (Harrison's, p. 8521)
2. Ultrafiltration (convection)
- Hydrostatic pressure gradient drives bulk water movement from blood to dialysate
- Solutes are "dragged" along with water (solvent drag) — important for middle molecule clearance
3. Osmosis
- Movement of water across the membrane due to osmotic pressure differences (minor role in HD)
Components of a Hemodialysis System
| Component | Details |
|---|---|
| Dialyzer | Contains semipermeable membrane (cellulose/synthetic); high-flux or low-flux |
| Dialysate | Buffered solution (bicarbonate-based); contains Na⁺, K⁺, Ca²⁺, Mg²⁺, glucose |
| Blood pump | Maintains blood flow at 200–400 mL/min |
| Vascular access | AV fistula (preferred), AV graft, or central venous catheter |
| Anticoagulation | Unfractionated heparin (most common); regional citrate or low-MW heparin if bleeding risk |
Indications
Chronic Indications (ESRD / CKD Stage 5)
- GFR <10 mL/min/1.73 m² (or <15 in diabetics)
- Leading causes of ESRD: Diabetic nephropathy, Hypertension, Chronic glomerulonephritis (Bailey & Love, p. 1623)
Acute Indications — Mnemonic "AEIOU"
| Letter | Indication |
|---|---|
| A | Acidosis — metabolic, refractory (pH <7.1) |
| E | Electrolyte disturbance — hyperkalemia (K⁺ >6.5 mEq/L, refractory) |
| I | Intoxication — dialyzable poisons (methanol, ethylene glycol, salicylates, lithium) |
| O | Overload — fluid/pulmonary edema unresponsive to diuretics |
| U | Uremia — symptomatic (encephalopathy, pericarditis, bleeding, nausea/vomiting) |
Vascular Access
Preferred order (NKF-KDOQI guidelines):
- Arteriovenous Fistula (AVF) — gold standard; radio-cephalic (Cimino-Brescia) or brachio-cephalic; lowest infection/thrombosis rate; requires 6–8 weeks maturation
- AV Graft (AVG) — synthetic (PTFE) conduit; usable in 2–3 weeks; higher thrombosis risk
- Central Venous Catheter (CVC) — temporary (non-tunneled) or long-term (tunneled, e.g., Permcath); highest infection/mortality risk; used when AVF/AVG unavailable
Procedure
- Blood drawn from vascular access at 200–400 mL/min via blood pump
- Anticoagulated with heparin (5000 IU bolus + 1000 IU/hr maintenance)
- Blood passes through dialyzer countercurrent to dialysate flow (500–800 mL/min)
- Purified blood returned to patient
- Session duration: 3.5–5 hours, typically 3 times per week
Adequacy of Hemodialysis
The adequacy of dialysis is quantified by Kt/V (urea kinetic modelling):
- K = dialyzer urea clearance (mL/min)
- t = time of session (min)
- V = volume of urea distribution (≈ total body water)
Target single-pool Kt/V (spKt/V):
- Minimum delivered: ≥1.2 per session
- Target: ≥1.4 per session (thrice-weekly schedule) (KDOQI Hemodialysis Adequacy Guidelines, p. 11)
Urea Reduction Ratio (URR):
- URR (%) = [(Pre-dialysis BUN − Post-dialysis BUN) / Pre-dialysis BUN] × 100
- Target: ≥65%
Complications
A. Acute / Intradialytic Complications
| Complication | Mechanism | Management |
|---|---|---|
| Hypotension (most common) | Excessive ultrafiltration, autonomic dysfunction, cardiac disease | Stop UF, IV isotonic saline 100–250 mL, reduce session rate |
| Muscle cramps | Rapid fluid/electrolyte shifts | Hypertonic saline, reduce UF rate |
| Disequilibrium syndrome | Rapid urea removal → cerebral edema | Slow first dialysis, mannitol |
| Air embolism | Air entry into circuit | Head-down left lateral position, O₂ |
| Dialyzer reaction | Complement activation / hypersensitivity | Antihistamines, stop session |
| Arrhythmias | Rapid K⁺/electrolyte shifts | Correct electrolytes |
B. Chronic Complications
- Cardiovascular disease — leading cause of mortality in dialysis patients; accelerated atherosclerosis
- Anemia — EPO deficiency; managed with recombinant EPO + IV iron
- Renal osteodystrophy — secondary hyperparathyroidism; managed with phosphate binders, active vitamin D, calcimimetics
- Malnutrition — protein-energy wasting; loss of amino acids in dialysate
- Amyloidosis — β₂-microglobulin deposition (carpal tunnel, destructive arthropathy)
- Access-related — AVF thrombosis, steal syndrome, high-output cardiac failure from AVF shunting (Harrison's, p. 8527)
- Infections — bacteremia, endocarditis (especially with CVC)
Dialysis vs. Peritoneal Dialysis — Key Differences
| Parameter | Hemodialysis | Peritoneal Dialysis |
|---|---|---|
| Membrane | Synthetic | Peritoneum |
| Access | Vascular | Peritoneal catheter |
| Frequency | 3×/week, 4–5 hrs | Daily (CAPD) or nightly (APD) |
| Hemodynamic stress | Higher | Lower |
| Protein loss | Less | More |
| Independence | Center-based | Home-based |
Special Points for Examination
- Dialysate composition: Na⁺ 135–145, K⁺ 1–4, Ca²⁺ 1.25–1.75, HCO₃⁻ 35–40 mmol/L; glucose added to prevent hypoglycemia
- High-flux dialyzers remove middle molecules (β₂-microglobulin) better than low-flux
- Heparin-free dialysis used in active bleeding — replaced by saline flushes or regional citrate anticoagulation
- Daily HD (6×/week, home HD) offers superior outcomes but limited access
- Mortality on HD: ~15–20% per year; cardiovascular events account for ~50% of deaths
Summary Box (for quick recall):
HD = Diffusion + Ultrafiltration | Access: AVF > Graft > CVC | Dose: Kt/V ≥1.4 (min 1.2), 3×/week | Most common acute complication: Hypotension | Most common cause of death: Cardiovascular disease
References: Harrison's Principles of Internal Medicine, 21st Edition (p. 8521, 8527); KDOQI Clinical Practice Guidelines for Hemodialysis Adequacy (p. 11); Bailey & Love's Short Practice of Surgery, 28th Edition (p. 1623)
Add mnemonic
Medical Text Search
hemodialysis mnemonics complications access adequacy
GradeResponse
Here is the complete answer with mnemonics woven in throughout every major section:
HEMODIALYSIS
Definition
Hemodialysis (HD) is an extracorporeal renal replacement therapy (RRT) in which blood is circulated outside the body through a dialyzer (artificial kidney) containing a semipermeable membrane, allowing removal of metabolic waste products, excess fluid, and correction of electrolyte and acid-base abnormalities. (Harrison's, p. 8521)
Principle of Hemodialysis
🧠 Mnemonic: "DUC" — the three transport mechanisms Diffusion → Ultrafiltration → Convection (solvent drag)
1. Diffusion (primary mechanism)
- Solutes move down a concentration gradient from blood to dialysate
- Rate depends on: concentration gradient, membrane surface area, mass transfer coefficient, molecular size
🧠 Mnemonic: "MASH" — factors affecting diffusion rate Membrane surface area | Area (porosity/thickness) | Size of molecule | Haemodynamics (flow conditions)
2. Ultrafiltration
- Hydrostatic pressure drives bulk water removal from blood
3. Convection (Solvent Drag)
- Solutes dragged along with water — important for middle molecule clearance
Components of the HD System
🧠 Mnemonic: "DAVID" — components of HD Dialyzer | Anticoagulant | Vascular access | Inflow/outflow lines (tubing) | Dialysate
| Component | Details |
|---|---|
| Dialyzer | Semipermeable membrane (synthetic/cellulose); high-flux or low-flux |
| Dialysate | Bicarbonate-buffered; contains Na⁺, K⁺, Ca²⁺, Mg²⁺, glucose |
| Blood pump | Maintains blood flow 200–400 mL/min |
| Vascular access | AVF (preferred) → AV graft → CVC |
| Anticoagulation | Unfractionated heparin; citrate/LMWH if bleeding risk |
Indications
Chronic Indications
- GFR <10 mL/min/1.73 m² (or <15 in diabetics) — ESRD
🧠 Mnemonic: "DHC" — leading causes of ESRD (Bailey & Love, p. 1623) Diabetic nephropathy | Hypertension | Chronic glomerulonephritis
Acute Indications
🧠 Mnemonic: "AEIOU" (classic, must-know) A — Acidosis (metabolic, refractory; pH <7.1) E — Electrolyte disturbance (hyperkalemia K⁺ >6.5 mEq/L, refractory) I — Intoxication (dialyzable poisons — methanol, ethylene glycol, salicylates, lithium) O — Overload (fluid/pulmonary edema unresponsive to diuretics) U — Uremia (symptomatic — encephalopathy, pericarditis, bleeding)
Vascular Access
🧠 Mnemonic: "FAG" — order of preference Fistula (AVF) → AV Graft → Catheter (CVC) "Fistula Always beats Graft beats Catheter"
| Access | Details |
|---|---|
| AVF (Fistula) | Gold standard; radio-cephalic (Cimino-Brescia); needs 6–8 weeks maturation; lowest infection risk |
| AV Graft | Synthetic PTFE; usable in 2–3 weeks; higher thrombosis risk |
| CVC (Catheter) | Tunneled (Permcath) or non-tunneled; highest infection and mortality risk; use only when AVF/AVG unavailable |
Procedure
🧠 Mnemonic: "BACH" — steps of HD procedure Blood drawn from access → Anticoagulation (heparin) → Circulation through dialyzer (countercurrent) → Home (blood returned purified)
- Blood flow rate: 200–400 mL/min
- Dialysate flow: 500–800 mL/min (countercurrent to blood)
- Heparin: 5000 IU bolus + 1000 IU/hr
- Session: 3.5–5 hours, 3× per week
Adequacy of Hemodialysis
🧠 Mnemonic: "KTV = Keep The Venom out" Kt/V measures how effectively urea (the "venom") is cleared
- K = Dialyzer urea clearance (mL/min)
- t = Time (min)
- V = Volume of distribution of urea (≈ total body water)
Targets (KDOQI Guidelines, p. 11):
- Minimum spKt/V: ≥1.2 per session
- Target spKt/V: ≥1.4 per session (thrice weekly)
- URR (Urea Reduction Ratio): ≥65%
URR = [(Pre-BUN − Post-BUN) / Pre-BUN] × 100
Complications
A. Acute / Intradialytic Complications
🧠 Mnemonic: "HAMCDA" — acute HD complications Hypotension | Air embolism | Muscle cramps | Cramps/Disequilibrium | Dialyzer reaction | Arrhythmia
| Complication | Mechanism | Management |
|---|---|---|
| Hypotension (most common) | Excessive UF, autonomic dysfunction, cardiac disease | Stop UF; IV saline 100–250 mL |
| Muscle cramps | Rapid fluid/electrolyte shifts | Hypertonic saline; reduce UF rate |
| Disequilibrium syndrome | Rapid urea removal → cerebral edema | Slow first dialysis; IV mannitol |
| Air embolism | Air entry into blood circuit | Head-down left lateral position; 100% O₂ |
| Dialyzer reaction | Complement activation / hypersensitivity | Antihistamines; stop session |
| Arrhythmias | Rapid K⁺/Ca²⁺ shifts | Correct electrolytes |
(Harrison's, p. 8527)
B. Chronic Complications
🧠 Mnemonic: "CAMRA" — chronic HD complications Cardiovascular disease (leading cause of death — ~50% mortality) Anemia (EPO deficiency → treat with rEPO + IV iron) Malnutrition (protein-energy wasting; amino acid loss in dialysate) Renal osteodystrophy (2° hyperparathyroidism → phosphate binders + vit D + calcimimetics) Amyloidosis (β₂-microglobulin deposition → carpal tunnel, destructive arthropathy)
Additional chronic complications:
- Access complications: AVF thrombosis, steal syndrome, high-output cardiac failure
- Infections: bacteremia, endocarditis (especially with CVC)
Dialysate Composition
🧠 Mnemonic: "SNAK-BG" — dialysate ions Sodium (135–145) | Not much potassium (1–4) | Acid buffer = bicarb | Kalcium/Ca²⁺ (1.25–1.75) | Bicarbonate (35–40) | Glucose (added)
HD vs. Peritoneal Dialysis
🧠 Mnemonic: "HOME vs HOSPITAL" PD = HOME (patient-controlled, continuous, gentler) HD = HOSPITAL (centre-based, intermittent, higher efficiency)
| Parameter | Hemodialysis | Peritoneal Dialysis |
|---|---|---|
| Membrane | Synthetic dialyzer | Peritoneum |
| Access | Vascular (AVF) | Peritoneal catheter |
| Frequency | 3×/week, 4–5 hrs | Daily CAPD or nightly APD |
| Hemodynamic stress | Higher | Lower |
| Protein loss | Less | More |
| Setting | Centre-based | Home-based |
Quick Revision Summary
🧠 Master Mnemonic for the whole topic: "DAVID AEIOU FAG KTV CAMRA"
Mnemonic Covers DUC Principles (Diffusion, UF, Convection) DAVID Components of HD system AEIOU Acute indications DHC Causes of ESRD FAG Vascular access order BACH Procedure steps KTV Adequacy (Kt/V ≥1.4, min 1.2; URR ≥65%) HAMCDA Acute complications CAMRA Chronic complications SNAK-BG Dialysate composition HOME vs HOSPITAL HD vs PD
References: Harrison's Principles of Internal Medicine, 21st Edition (p. 8521, 8527); KDOQI Clinical Practice Guidelines for Hemodialysis Adequacy (p. 11); Bailey & Love's Short Practice of Surgery, 28th Edition (p. 1623)
This is a shared conversation. Sign in to Orris to start your own chat.